A detailed history of Td Asset Management Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Td Asset Management Inc holds 302,724 shares of BCRX stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
302,724
Previous 240,600 25.82%
Holding current value
$2.32 Million
Previous $1.49 Million 54.78%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$6.41 - $8.69 $398,214 - $539,857
62,124 Added 25.82%
302,724 $2.3 Million
Q2 2024

Aug 02, 2024

BUY
$4.13 - $6.79 $993,678 - $1.63 Million
240,600 New
240,600 $1.49 Million

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.